Rosavin: Research Advances in Extraction and Synthesis, Pharmacological Activities and Therapeutic Effects on Diseases of the Characteristic Active Ingredients of IRhodiola rosea/I L

• Published in: Molecules (Basel, Switzerland) Switzerland), 2023-11, Vol.28 (21)
• Main Authors: Wang, Shen, Feng, Yanmin, Zheng, Lin, He, Panfeng, Tan, Jingyi, Cai, Jinhui, Wu, Minhua, Ye, Xiaoxia
• Format: Article
• Language: English
• Subjects: Antioxidants; B cells; Chronic diseases; Development and progression; Health aspects; Medical research; Medicine, Experimental
• ISSN: 1420-3049; 1420-3049
• DOI: 10.3390/molecules28217412

Rhodiola rosea L. (RRL) is a popular plant in traditional medicine, and Rosavin, a characteristic ingredient of RRL, is considered one of the most important active ingredients in it. In recent years, with deepening research on its pharmacological actions, the clinical application value and demand for Rosavin have been steadily increasing. Various routes for the extraction and all-chemical or biological synthesis of Rosavin have been gradually developed for the large-scale production and broad application of Rosavin. Pharmacological studies have demonstrated that Rosavin has a variety of biological activities, including antioxidant, lipid-lowering, analgesic, antiradiation, antitumor and immunomodulation effects. Rosavin showed significant therapeutic effects on a range of chronic diseases, including neurological, digestive, respiratory and bone-related disorders during in vitro and vivo experiments, demonstrating the great potential of Rosavin as a therapeutic drug for diseases. This paper gives a comprehensive and insightful overview of Rosavin, focusing on its extraction and synthesis, pharmacological activities, progress in disease-treatment research and formulation studies, providing a reference for the production and preparation, further clinical research and applications of Rosavin in the future.